The Committee for Medicinal Products for Human Use (CHMP) is a key committee within the European Medicines Agency (EMA). It is responsible for preparing the agency's opinions on all matters regarding the marketing of human medicines in the European Union. This includes evaluating the safety, efficacy, and quality of these medicines, which is crucial for gynecological health treatments.
